Summary
We have initiated clinical selective screening for inborn errors of metabolism in China by analysing amino acids and acylcarnitines in a dried blood filter-paper samples using tandem mass spectrometry. Samples from a total of 3070 children suspected of inborn errors of metabolism were collected through a study network which covered most provinces of China. The diagnoses were further confirmed through clinical symptoms, by gas chromatography–mass spectrometry and other biochemistry studies, and in a few cases by DNA analysis. In all, 212 cases were diagnosed (6.6%) including 92 (43.4%) with amino acids disorders (48 with phenylketonuria, 12 with ornithine carbamoyltransferase deficiency, 7 with tyrosinaemia type I, 9 with maple syrup urine disease, 5 with citrullinaemia type I, 8 with citrullinaemia type II, 2 with homocystinuria, and 1 with argininaemia); 107 (50.5%) with organic acid disorders (including 58 with methylmalonic acidaemia, 13 with propionic acidaemia, 6 with isovaleric acidaemia, 7 with glutaric acidaemia type I, 6 with 3-methylcrotonyl-CoA carboxylase deficiency, 2 with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency, 10 with multiple carboxylase deficiency, and 5 with β-ketothiolase deficiency); and 13 (6.1%) with fatty acid oxidation disorders (including 1 with carnitine palmitoyltransferase deficiency type I, 1 with carnitine palmitoyltransferase deficiency type II, 1 with short-chain acyl-CoA dehydrogenase deficiency, 5 with medium-chain acyl-CoA dehydrogenase deficiency, 3 with very long-chain acyl-CoA dehydrogenase deficiency, and 2 with multiple acyl-CoA dehydrogenase deficiency). It is suggested that tandem mass spectrometry is useful for selective screening of clinically suspected patients. The majority of diseases (94%) in this study were amino acid disorders and organic acid disorders. Fatty acid oxidation disorders are relatively rare in the Chinese, but medium-chain acyl-CoA dehydrogenase deficiency should be further investigated.
Similar content being viewed by others
References
Allardaa P, Grenierb A, Korson MS, et al (2004) Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots. Clin Biochem 37: 1010–1015.
Chace DH, DiPerna JC, Kalas TA, et al (2001) Rapid diagnosis of methylmalonic and propionic acidemias: quantitive tandem mass spectrometry analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns. Clin Chem 47: 2040–2044.
Chace DH, Kalas TA (2005) A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin Biochem 38: 296–309.
Dott M, Chace D, Fierro M, et al (2006) Metabolic disorders detectable by tandem mass spectrometry and unexpected early childhood mortality: a population-based study. Am J Med Genet 140A: 837–842.
Frazier DM, Millington DS, McCandless SE, et al (2006) The tandem mass spectrometry newborn screening experience in North Carolina: 1997–2005. J Inherit Metab Dis 29: 76–85.
Hoffmann GF, Kries R, Klose D, et al (2004) Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany. Eur J Pediatr 163: 76–80.
Maier EM, Liebl B, Roschinger W, et al (2005) Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency. Hum Mutat 25: 443–452.
Pasquali M, Monsen G, Richardson L (2006) Biochemical findings in common inborn errors of metabolism. Am J Med Genet Part C 142C: 64–76.
Saudubray JM, Sedel F, Walter JH (2006) Clinical approach to treatable inborn metabolic disorders: an introduction. J Inherit Metab Dis 29: 261–274.
Schulze A, Lindner M, Kohlmuller D, et al (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111: 1399–1406.
Shigematsu Y, Hirano S, Hata I, et al (2002) Newborn mass screening and selective screening using elctrospray tandem mass spectrometry in Japan. J Chromatogr B 776: 39–48.
Wajner M, Raymond K, Barschak A, et al (2002) Detection of organic acidemias in Brazil. Arch Med Res 33: 581–585.
Xuefan Gu, Lianshu Han, Xiaolan Gao, et al (2004) A pilot study of selective screening in high risk children with inborn error of metabolism using tandem mass spectrometry. Chin J Pediatr 42: 401–404.
Yang YL, Songn F, Qian N, et al ( 2005) Clinical and laboratory screening studies on urea cycle defects. Chin J Pediatr 45: 331–334.
Yoon HR, Lee KR, Kang S, et al (2005) Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clin Chim Acta 354: 167–180.
Zytkovicz TH, Fitzgerald EF, Marsden D, et al (2001) Tandem mass spectrometry analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 47: 1945–1955.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Rodney Pollitt
Competing interests: None declared
References to electronic databases: Propionic acidemia (OMIM 606054); very long-chain acyl-CoA dehydrogenase deficiency (OMIM 201475); medium-chain acyl-CoA dehydrogenase deficiency (OMIM 201450); ornithine transcarbamylase deficiency (OMIM 300461); maple syrup urine disease (OMIM 248600); tyrosinaemia type I (OMIM 276700); citrullinaemia type II (OMIM 603471); multiple carboxylase deficiency, very long-chain acyl-CoA dehydrogenase deficiency (OMIM 201475); medium-chain acyl-CoA dehydrogenase deficiency (OMIM 201450)
Rights and permissions
About this article
Cite this article
Han, L.S., Ye, J., Qiu, W.J. et al. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: A four-year report. J Inherit Metab Dis 30, 507–514 (2007). https://doi.org/10.1007/s10545-007-0543-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-007-0543-9